ADC Therapeutics
ADCT
ADC Therapeutics (ADCT) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Guggenheim | Maintained | Buy | $5.00 from $10.00 | Aug 17, 2026 |
| HC Wainwright & Co. | Downgraded | Buy → Neutral | — | Jun 8, 2026 |
| RBC Capital | Downgraded | Outperform → Sector Perform | $2.00 from $6.00 | Jun 4, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $8.00 | May 5, 2026 |
| RBC Capital | Maintained | Outperform | $6.00 | May 5, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $8.00 from $7.00 | Mar 23, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 from $8.00 | Oct 16, 2025 |
| Guggenheim | Maintained | Buy | $10.00 | Aug 13, 2025 |
| RBC Capital | Maintained | Outperform | $5.00 from $8.00 | Jun 20, 2025 |
| Guggenheim | Maintained | Buy | $10.00 from $7.00 | Jun 13, 2025 |
| RBC Capital | Maintained | Outperform | $8.00 | May 15, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $8.00 | Mar 31, 2025 |
| Guggenheim | Maintained | Buy | $7.00 from $10.00 | Mar 31, 2025 |
| Cantor Fitzgerald | Maintained | Overweight | — | Mar 7, 2025 |
| Stephens & Co. | Maintained | Overweight | $8.00 from $6.00 | Feb 24, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $8.00 | Jan 6, 2025 |
| Guggenheim | Maintained | Buy | $10.00 | Dec 12, 2024 |
| HC Wainwright & Co. | Maintained | Buy | — | Dec 11, 2024 |
| Stephens & Co. | Initiated Coverage | Overweight | $6.00 | Nov 8, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $8.00 | Aug 8, 2024 |
Frequently asked questions
What is the latest analyst rating on ADCT?
On Aug 17, 2026, Guggenheim maintained ADC Therapeutics at Buy with a price target of $5.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.